Psychopharmacology research in the English-speaking Caribbean

Drug Metabolism and Drug Interactions

Volumn 16, Issue 1, 2000, Pages 69-80

  Montane Jaime, L K ^a   Maharajh, Hari ^b  

^a UNIVERSITY OF THE WEST INDIES   (Trinidad and Tobago)

^b St Ann's Hospital   (Trinidad and Tobago)

Author keywords

English speaking Caribbean; Ethnicity; Psychopharmacology

Indexed keywords

ALCOHOL; BENZODIAZEPINE; CANNABIS; CLOMIPRAMINE; CLOZAPINE; COCAINE; CREATINE KINASE; FLUPHENAZINE; HALOPERIDOL; IMIPRAMINE; LITHIUM; PHENOTHIAZINE DERIVATIVE; PSYCHOTROPIC AGENT;

AGRANULOCYTOSIS; ALCOHOLISM; ARTICLE; CARIBBEAN ISLANDS; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INFORMATION; ETHNOLOGY; HUMAN; NEUROLEPTIC MALIGNANT SYNDROME; PREDICTION; PSYCHOPHARMACOLOGY; TARDIVE DYSKINESIA; TREATMENT OUTCOME;

CARIBBEAN REGION; HUMANS; MENTAL DISORDERS; PSYCHOPHARMACOLOGY; PSYCHOTROPIC DRUGS; RESEARCH; SUBSTANCE-RELATED DISORDERS;

EID: 0033950288     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Turner SM, Cooley-Quille R Sociological and sociocultural variables in psychopharmacological research: Methodological considerations. Psychopharmacol Bull 1996; 32: 183-192.
2. Lin K-M, Poland RE, Wan W, et al. The evolving science of pharmacogenetics: Clinical and ethnic perspectives. Psychopharmacol Bull 1996; 32: 205-217.
3. CSO Population. Republic of Trinidad and Tobago: Central Statistical Office, 1990.
4. Mahy GE. The effects of clomipramine on depression in Barbadian patients. West Indian Med J 1978; 27: 75-80.
5. Mahy GE. Fluphenazine enanthate in a community psychiatric programme. West Indian Med J 1975; 24: 61-64.
6. Neehall J. Tardive dyskinesia in outpatients on depot phenothiazine. West Indian Med J 1989; 38: 228-233.
7. Beaubrun MH, Patrick AL. The neuroleptic malignant syndrome (N.M.S.) in a West Indian of African descent. West Indian Med J 1987; 36: 48-50.
8. Maharajh HD. The effect of high rapid loading and reloading doses in provoking neuroleptic malignant syndrome. West Indian Med. J 1988; 37 (Suppl): 44.
9. Mansoor GA, Corbin DO, Edwards CN, et al. Neuroleptic malignant syndrome among acute psychiatric admissions in Barbados. West Indian Med J 1992; 41: 15-18.
10. Maharajh HD. CPK levels and neuroleptic malignant syndrome. Br J Psychiatry 1989; 154: 885-886.
11. Mahy GE. Neurological sequelae of lithium therapy. West Indian Med J 1984; 33: 272-274.
12. Beaubrun MH Alcohol and alcoholism. Caribbean Med J 1957; 19: 137-142.
13. Patrick AL, Beaubrun MH, Patrick-Boyd HA. Alcohol consumption patterns in two Caribbean islands: The CAGE questionnaire as a predictor of mortality. West Indian Med J 1996; 45 (Suppl 2): 34.
14. Soyibo K, Lee MG. Use of alcohol, tobacco and non-prescription drugs among Jamaican high school students. West Indian Med J 1997; 46: 111-114.
15. Grol ME, Halabi YT, Gerstenbluth I, et al. Lifestyle in Curacao. Smoking, alcohol consumption, eating habits and exercise. West Indian Med J 1997; 46: 8-14.
16. Beaubrun MH. Factors affecting the incidence and treatment of alcoholism in the Caribbean. Caribbean Med J 1975; 36: 40-41.
17. Mansoor GA, Edwards CN. Questionnaire detection of problem drinkers among acute medical admissions. West Indian Med J 1991; 40: 65-68.
18. Beaubrun M. The nature of alcohol dependence and its recognition. Med Digest 1982; 8: 5-13.
19. Patrick AL, Beaubrun MH, Patrick-Boyd HA. Cardiovascular risk factors and alcohol consumption study of Tobago Caribbean Med J 1996; 41:4.
20. Beaubrun MH, Thomas C, McFarlane H, et al Blood alcohol concentrations of motor vehicle accident victims at the Port of Spain general hospital casualty department: A preliminary report. West Indian Med J 1986; 35 (Suppl): 55.
21. Francis M, Eldemire D, Clifford R. A pilot study of alcohol and drug-related traffic accidents and death in two Jamaican parishes, 1991. West Indian Med J 1995; 44: 99-101.
22. Beaubrun MH. Treatment of alcoholism in Trinidad and Tobago, 1956-65. Br J Psychiatry 1967; 113. 643-658.
23. Hosein IN, De Freitas R, Beaubrun MH. Intramuscular/oral lorazepam in acute alcohol withdrawal and incipient delirium tremens. West Indian Med J 1979; 28: 45-48.
24. Maharajh HD. Family therapy of alcoholism outcome and evaluation. West Indian Med J 1986; 37 (Suppl): 19.
25. Maharajh HD, Bhugra D. Brief family therapy with alcohol-dependent men in Trinidad and Tobago. Acta Psychiatr Scand 1993, 87: 422-426.
26. Parasram R. Ethnic differences in reported rates of alcoholism in Trinidad and Tobago. Presented at International Congress on Alcoholism and Drug Dependence, Alberta, August, 1995.
27. Montane LK, Maharajh H. Ethnic differences in the incidence rates of mental disorders in county Caroni, Trinidad. West Indian Med J 1998; 48 (Suppl 2): 50.
28. Wray SR, Murthy NV. Review of the effects of cannabis on mental and physiological functions. Justification for an intensive and comprehensive programme for the health of the Caribbean people. West Indian Med J 1987; 36: 197-201.
29. Spencer DJ. Cannabis induced psychosis West Indian Med J 1970; 19: 228-230.
30. Beaubrun MH. Psychiatric assessment of 30 chronic users of cannabis and 30 matched controls. Am J Psychiatry 1973; 130: 309-311.
31. Knight F. Role of cannabis in psychiatric disturbance. West Indian Med J 1991; 40: 120-123.
32. Hayes JS, Lampart R, Dreher MC, et al. Five-year follow-up of rural Jamaican children whose mothers used marijuana during pregnancy. West Indian Med J 1991; 40: 120-123.
33. Simeon DT, Bain BC, Wyatt GE, et al. Characteristics of Jamaicans who smoke marijuana before sex and their risk status for sexually transmitted diseases. West Indian Med J 1996; 45. 9-13.
34. Wray SR. Drug abuse and mental health. West Indian Med J 1986; 35: 1-3.
35. Wray SR, Young LE Consequences of substance abuse. Future generations at risk. West Indian Med J 1992; 41: 47-48.
36. Beaubrun MH. Cocaine update. Caribbean Med J 1986; 47: 12-17.
37. Maharajh HD, Dutta A, Gopeesingh SR. Cocaine addiction in Trinidad and Tobago. West Indian Med J 1987; 36 (Suppl): 13.
38. Maharajh HD. Therapeutic addictions: The abuse of prescription drugs and other pharmaceuticals in Trinidad and Tobago. Caribbean Med J 1989; 50: 27-30.
39. Lewis PD, Hospedales CJ. HIV study of cocaine dependent persons. West Indian Med J 1991; 40 (Suppl 1): 25.
40. Singh HN, Maharajh HD, Shipp M. Patterns of substance abuse among secondary school children in Trinidad and Tobago, Br J Public Health 1991; 105: 435-441.
41. Hutchinson G, Greenidge C, Lewis P. Sociodemographic features of cocaine dependence. West Indian Med J 1992; 46 (Suppl): 67.
42. Maharajh HD, Cocaine and social transformation in Trinidad and Tobago. Psychiatr Bull 1997; 21: 184-185.
43. Daisley H, Jones-Le Cointe A, Hutchinson G, et al. Fatal cardiac toxicity temporally related to poly-drug abuse. Vet Hum Toxicol 1998, 40: 21-22.
44. Bond WS. Ethnicity and psychotropic drugs Clin Pharmacol 1990; 10: 467-470.
45. Lin K-M, Poland RE, Smith MW, et al. Pharmacokinetics and other related factors affecting psychotropic response in Asians. Psychopharmacol Bull 1991; 27: 427-439.
46. Mendoza R, Smith W, Poland RE, et al Ethnic psychopharmacology: The Hispanic and native American perspective. Psychopharmacol Bull 1991; 27: 449-461.
47. Pi EH, Wang AL, Gray GE. Asian/non-Asian transcultural tricyclic antidepressant psychopharmacology: a review. Prog Neuro-psychopharmacol Biol Psychiat 1993; 17: 691-702.
48. Strickland TL, Ranganath V, Lin K-M, et al. Psychopharmacologic considerations in the treatment of black American populations. Psychopharmacol Bull 1991; 4: 441-448.
49. Strickland TL, Lin K-M, Fu P, et al. Comparison of lithium ratio between African-American and Caucasian bipolar patients. Biol Psychiatry 1995; 37: 325-330.
50. Overall JE, Hollister LE, Kimbell I, et al. Extrinsic factors influencing response to psychotherapeutic drugs. Arch Gen Psychiat 1969; 21: 89-94.
51. Henry BW, Overall JE, Markette JR, et al. Comparison of major drug therapies for alleviation of anxiety and depression. Dis Nerv Syst 1971; 32: 655-677.
52. Raskin A, Crook TH. Antidepressants in black and white patients. Arch Gen Psychiat 1975; 32: 643-649.
53. Lawson WE. Racial and ethnic factors in psychiatric research. Hosp Community Psychiat 1986; 37: 50-54.
54. Silver B, Poland RE, Lin K-M. Ethnicity and the pharmacology of tricyclic antidepressants. In: Lin K-M, Poland RE, Nakasaki G, eds. Psychopharmacology and Psychobiology of Ethnicity. Washington, DC. American Psychiatric Association, 1993; 61-89.
55. Strickland TL, Lawson W, Lin K-M, et al. Interethnic variation in response to lithium therapy among African-American and Asian-American populations. In: Lin K-M, Poland RE, Nakasaki G, eds. Psychopharmacology and Psychobiology of Ethnicity. Washington, DC: American Psychiatric Association, 1993; 61-89.
56. Zieggler VE, Biggs JT. Tricyclic plasma levels - effect of age, race, sex and smoking. JAMA 1977; 238: 2167-2169.
57. Rudorfer MV, Robins E. Amitriptyline overdose: Clinical effects on tricyclic antidepressant plasma levels. J Clin Psychiat 1982; 43: 457-460.
58. Glazer WM, Morgesnstern H, Doucette J. Race and tardive dyskinesia among outpatients at a CMHC. Hosp Community Psychiat 1994; 5: 38-42.
59. Yamashita I, Asano Y. Tricyclic antidepressants: therapeutic plasma levels in Chinese bipolar patients. Psychopharmacol Bull 1979; 15: 40-41.
60. Kleinman A. Culture and patient care: psychiatry among the Chinese. Drug Ther 1981; 11: 134-140.
61. Kinzie JD, Leung P, Boehnlein JK, et al. Antidepressant blood levels in Southeast Asians - clinical and cultural implications. J Nerv Ment Dis 1987; 175: 480-485.
62. Rosenblat R, Tang SW. Do Oriental psychiatric patients receive different dosages of psychotropic medication when compared with Occidentals? Can J Psychiat 1987; 32: 270-274.
63. Lin K-M, Finder E. Ethnicity and psychopharmacology. Bridging the gap. Psychiatr Clin N Am 1983; 18: 635-647.
64. Lin K-M, Poland RE, Nuccio I, et al. A longitudinal assessment of haloperidol dosage and serum concentrations in Asian and Caucasian schizophrenic patients. Am J Psychiat 1989; 146: 1307-1311.
65. Lin K-M, Poland RE. Ethnicity, culture and psychopharmacology. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York: Raven Press Ltd., 1995; 1907-1917.
66. Potkin SG, Shen T, Pardes H, et al. Haloperidol concentrations elevated in Chinese patients. Psychiat Res 1984; 12: 167-172.
67. Lin K-M, Poland RE, Lau JK, et al. Haloperidol and prolactin concentrations in Asians and Caucasians. J Clin Psychopharmacol 1988; 8: 195-201.
68. Jann MW, Chang WH, Davis CM, et al. Haloperidol and reduced haloperidol plasma levels in Chinese vs. non-Chinese psychiatric patients. Psychiat Res 1989; 30: 45-52.
69. Matsuda KT, Cho MC, Lin K-M, et al. Clozapine dosage, serum levels, efficacy, and side-effect profiles: a comparison of Korean-American and Caucasian patients. Psyhopharmacol Bull 1996; 32: 253-257.
70. Lin K-M, Poland RE, Nagasaki G. Psychopharmacology and Psychobiology of Ethnicity. Washington, DC: American Psychiatry Press, 1993.
71. Takahashi R. Lithium treatment in affective disorders: therapeutic plasma level. Psychopharmacol Bull 1979; 15: 32-35.
72. Yang W. Prophylactic efficacy of lithium and its effective plasma levels in Chinese bipolar patients. Acta Psychiatr Scand 1985; 71: 171-375.
73. Kumana CR, Lauder IJ, Chan M et al. Differences in diazepam pharmacokinetics in Chinese and white Caucasians - Relation to body lipid stores. Eur J Clin. Pharmacol 1987; 32: 211-215.
74. Zhang Y, Reviriego J, Lou Y, et al. Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-rnephenytoin; interethnic differences in comparison with white subjects. Pharmacol Ther 1990; 48: 496-502.
75. Marcos LR, Cranco R. Pharmacotherapy of Hispanic depressed patients: clinical observations. Am J Psychother 1982; 36: 505-512.
76. Ramirez LF. Ethnicity and psychopharmacology in Latin America Mt Sinai J Med 1996; 63: 330-331.
77. Alien JJ, Rack PH, Vaddaki KS. Differences in the effects of clomipramine on English and Asian volunteers: Preliminary report on a pilot study. Postgrad Med J 1977; 53 (Suppl 4): 79-86.
78. Lieberman JA, Yunis J. HLA-B38, DR4, DQw3 and clozapine induced agranulocytosis in Jewish patients with schizophrenia. Arch Gen Psychiat 1990; 47: 945-948.
79. Smith MW, Mendoza RP. Ethnicity and pharmacogenetics. Mt Sinai J Med 1996; 63: 285-290.
80. Kalow W. Interethnic variations of drug metabolism. Trends Pharmacol Sci 1991; 12: 102-107.